← All stocks

Compass Therapeutics, Inc.

CMPX No buying or selling

CIK 0001738021 #3229 in the set updated 18 Sep 2026

Bought (12 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$0.00

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$0.00

0 of 0 sales

Net

$0.00

$0.00 against sales at will

By person

6 insiders · 0 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Schuetz Thomas J.

CHIEF EXECUTIVE OFFICER

—

6,603,336

3.67%

$13.93M

+0.5%

Shin Barry

CFO

—

525,000

0.2915%

$1.11M

—

Lerner Neil

Chief Accounting Officer

—

397,500

0.2207%

$838.73K

+32.5%

Anderman Jonathan

General Counsel

—

196,000

0.1088%

$413.56K

+19,500%

ORBIMED ADVISORS LLC entity

Director

—

0.0000%

$0.00

−100.0%

GORDON CARL L

Director

—

0.0000%

$0.00

−100.0%

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 17

Amendments (4/A) skipped 2

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 754,989

History held since 23 Jun 2020